C.Q. Pharma’s Prasugrel Clinical Filing Accepted by China’s NMPA
China-based C.Q. Pharmaceutical Holding Co., Ltd (SHE: 000950) announced that its clinical application for prasugrel...
SHE: 000950
C.Q. Pharmaceutical Holding to Come Under SASAC’s Indirect Control via Genertec Acquisition
C.Q. Pharmaceutical Holding Co., Ltd (SHE: 000950), a Chongqing-based pharmaceutical company, is set to be...
Novartis Forges Partnerships at CIIE to Strengthen Radioligand Therapy Ecosystem in China
At the 7th China International Import Expo (CIIE), Swiss pharmaceutical giant Novartis (NYSE: NVS) announced...
C.Q. Pharmaceutical and JD.com Join Forces to Revolutionize Pharmaceutical Supply Chain
C.Q. Pharmaceutical Holding Co., Ltd (SHE: 000950), a prominent Chinese pharmaceutical company, has announced a...